Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer
- PMID: 33145325
- PMCID: PMC7575985
- DOI: 10.21037/atm-20-4143
Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer
Abstract
Esophageal cancer (EC) and gastric cancer (GC) carry a high mortality rate. Unfortunately, a majority of patients are asymptomatic and at the time of diagnosis, the disease may invariably be in its advanced stages with limited curative options. Thus, it is imperative to recognize certain risk factors including gastroesophageal reflux disease (GERD), male gender, pre-existing Barrett's esophagus, smoking history, obesity, Helicobacter pylori infection, atrophic gastritis among others for both EC and GC, intervene on time with screening and surveillance modalities if indicated and optimize treatment plans. With advances in endoscopic techniques, early neoplastic lesions are increasingly managed by gastroenterologists, offering an alternative to surgery. The gold standard for diagnosis of EC and GC is high definition endoscopy with adequate targeted biopsies. Endoscopic ultrasound (EUS) is a key in the staging of early cancers dictating the pathway for treatment options. We also play a key role in palliation cases with the aim to reduce the symptoms like nausea, vomiting and even when possible, restore oral intake and improve nutrition in both advanced GC and EC. This review article discusses the risk factors, diagnostic and endoscopic treatment modalities of early EC and GC and palliation of advanced cancer where gastroenterologists play a key role.
Keywords: Esophageal; cancer; endoscopic ultrasound (EUS); gastric.
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-4143). The series “Gastroesophageal Cancer 2020” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.
Figures



Similar articles
-
Recent advances in oesophageal diseases.Gastroenterol Hepatol Bed Bench. 2014 Summer;7(3):186-9. Gastroenterol Hepatol Bed Bench. 2014. PMID: 25120902 Free PMC article.
-
Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.Dis Esophagus. 1997 Jan;10(1):38-42. doi: 10.1093/dote/10.1.38. Dis Esophagus. 1997. PMID: 9079272
-
The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy.Am J Surg Pathol. 1996;20 Suppl 1:S31-50. doi: 10.1097/00000478-199600001-00005. Am J Surg Pathol. 1996. PMID: 8694147 Review.
-
Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.Am J Gastroenterol. 2002 Feb;97(2):302-11. doi: 10.1111/j.1572-0241.2002.05462.x. Am J Gastroenterol. 2002. PMID: 11866266
-
AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.Gastroenterology. 2020 Feb;158(3):760-769. doi: 10.1053/j.gastro.2019.09.051. Epub 2019 Nov 12. Gastroenterology. 2020. PMID: 31730766 Review.
Cited by
-
The Diagnosis of Early Gastric Cancer Based on Medical Imaging Technology and Mathematical Modeling.Comput Math Methods Med. 2022 Oct 3;2022:8721654. doi: 10.1155/2022/8721654. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Jun 28;2023:9867187. doi: 10.1155/2023/9867187. PMID: 36226247 Free PMC article. Retracted.
References
-
- Siewert R, Lepsien G, Peiper HJ. [Carcinoma of the esophagus and cardia]. Internist (Berl) 1977;18:451-62. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous